drugset / Trial / NCT04371627
Viaskin® Peanut (DBV712) Expanded Access Protocol
Summary
This is an open label expanded access program for male and female patients ≥ 4 years old.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Viaskin Peanut | Protein / enzyme biologic | — | Other |